These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35013079)

  • 1. Current evidence for focal laser ablation and vascular-targeted photodynamic therapy for localized prostate cancer: review of literature published in the last 2 years.
    Candela L; Kasraeian A; Barret E
    Curr Opin Urol; 2022 Mar; 32(2):192-198. PubMed ID: 35013079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular-targeted Photodynamic Therapy in Unilateral Low-risk Prostate Cancer in Germany: 2-yr Single-centre Experience in a Real-world Setting Compared with Radical Prostatectomy.
    Flegar L; Buerk B; Proschmann R; Propping S; Groeben C; Baunacke M; Herout R; Huber J; Thomas C; Borkowetz A
    Eur Urol Focus; 2022 Jan; 8(1):121-127. PubMed ID: 33602642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
    Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
    Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.
    Lepor H; Llukani E; Sperling D; Fütterer JJ
    Eur Urol; 2015 Dec; 68(6):924-6. PubMed ID: 25979568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for localized prostate cancer.
    Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
    Chao B; Llukani E; Lepor H
    Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
    Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
    BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.
    van Luijtelaar A; Greenwood BM; Ahmed HU; Barqawi AB; Barret E; Bomers JGR; Brausi MA; Choyke PL; Cooperberg MR; Eggener S; Feller JF; Frauscher F; George AK; Hindley RG; Jenniskens SFM; Klotz L; Kovacs G; Lindner U; Loeb S; Margolis DJ; Marks LS; May S; Mcclure TD; Montironi R; Nour SG; Oto A; Polascik TJ; Rastinehad AR; De Reyke TM; Reijnen JS; de la Rosette JJMCH; Sedelaar JPM; Sperling DS; Walser EM; Ward JF; Villers A; Ghai S; Fütterer JJ
    World J Urol; 2019 Oct; 37(10):2147-2153. PubMed ID: 30671638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation energies for focal treatment of prostate cancer.
    Lodeizen O; de Bruin M; Eggener S; Crouzet S; Ghai S; Varkarakis I; Katz A; Dominguez-Escrig JL; Pahernik S; de Reijke T; de la Rosette J
    World J Urol; 2019 Mar; 37(3):409-418. PubMed ID: 29943219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).
    Noweski A; Roosen A; Lebdai S; Barret E; Emberton M; Benzaghou F; Apfelbeck M; Gaillac B; Gratzke C; Stief C; Azzouzi AR
    Eur Urol Focus; 2019 Nov; 5(6):1022-1028. PubMed ID: 29661587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular targeted photodynamic therapy in low-risk prostate cancer. A literature review].
    Kleinclauss F; Frontczak A; Balssa L; Lebdai S; Azzouzi R
    Prog Urol; 2019; 29(8-9):393-401. PubMed ID: 31266699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-operator experience using EchoLaser SoracteLiteTM for focal laser ablation of prostate cancer: One more arrow in the quiver for the conservative management of the disease.
    Meneghetti I; Giardino D; Morganti R; Marino V; Menchini Fabris F; Bartoletti R; Pinzi N
    Arch Ital Urol Androl; 2022 Dec; 94(4):406-412. PubMed ID: 36576471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary treatments in prostate cancer focal therapy.
    Ahdoot M; Lebastchi AH; Turkbey B; Wood B; Pinto PA
    Curr Opin Oncol; 2019 May; 31(3):200-206. PubMed ID: 30865133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment.
    Chelly S; Maulaz P; Bigot P; Azzouzi AR; Lebdai S
    Asian J Androl; 2020; 22(5):454-458. PubMed ID: 31939351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
    Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
    Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laser in prostate cancer. Applicability.].
    Yebes A; Gómez Rivas J; Toribio C; Álvarez-Maestro M; Cansino R; Aguilera A; Martínez-Piñeiro L
    Arch Esp Urol; 2020 Oct; 73(8):724-734. PubMed ID: 33025917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of focal therapy in the management of localised prostate cancer: a systematic review.
    Valerio M; Ahmed HU; Emberton M; Lawrentschuk N; Lazzeri M; Montironi R; Nguyen PL; Trachtenberg J; Polascik TJ
    Eur Urol; 2014 Oct; 66(4):732-51. PubMed ID: 23769825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years.
    Kayano PP; Klotz L
    Curr Opin Urol; 2021 Jan; 31(1):49-57. PubMed ID: 33196540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease.
    Walser E; Nance A; Ynalvez L; Yong S; Aoughsten JS; Eyzaguirre EJ; Williams SB
    J Vasc Interv Radiol; 2019 Mar; 30(3):401-409.e2. PubMed ID: 30819483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer.
    Lebdai S; Villers A; Barret E; Nedelcu C; Bigot P; Azzouzi AR
    World J Urol; 2015 Jul; 33(7):965-71. PubMed ID: 25614256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.